In line with the above, several studies have also assessed the effect of the TNF-α antagonists on the mechanisms associated with accelerated atherogenesis in RA, including specifically the effect of these biologic agents on insulin resistance. The gene discussed is TNF; the disease is rheumatoid arthritis.